RAD 202 receives approval to start Phase 1 therapeutic trial

By admin 2 days ago0 view

Radiopharm Theranostics (RAD:AU) has announced RAD 202 receives approval to start Phase 1 therapeutic trial

Download the PDF here.

This post appeared first on investingnews.com

admin

Website

House Republicans agree on Plan B government funding bill with Trump’s debt limit increase

Top 5 Canadian Mining Stocks This Week: Omineca Jumps 67 Percent

The S&P/TSX Venture Composite Index (INDEXTSI:JX) fell 2.87 percent on the week to close at ...

admin

21Dec2024

Opawica Announces the Closing of Non-Brokered Private Placement

(TheNewswire) December 20th, 2024 Vancouver, B.C. TheNewswire – Opawica Explorations Inc. (TSXV: OPW) (FSE: A2PEAD) ...

admin

Stay updated with the latest news, exclusive offers, and special promotions. Sign up now and be the first to know! As a member, you'll receive curated content, insider tips, and invitations to exclusive events. Don't miss out on being part of something special.

Your name

Your email

By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

RAD 202 receives approval to start Phase 1 therapeutic trial

House Republicans agree on Plan B government funding bill with Trump’s debt limit increase

Malls are using new restaurants to draw consumers as shopping centers reinvent themselves

Popular News

House Republicans agree on Plan B government funding bill with Trump’s debt limit increase

Malls are using new restaurants to draw consumers as shopping centers reinvent themselves

You may also like

Top 5 Canadian Mining Stocks This Week: Omineca Jumps 67 Percent

Opawica Announces the Closing of Non-Brokered Private Placement

Popular News